Test Price
2,800 AED✅ Home Collection Available
GJC2 Gene Hereditary Lymphedema Type IC Genetic Test – 2800 AED | Dubai, UAE
Executive Summary & Core Metrics
Executive Summary
This Next‑Generation Sequencing (NGS) test detects pathogenic variants in the GJC2 gene to confirm hereditary lymphedema type IC. The analysis is performed under ISO‑accredited processes, ensuring 99.9% diagnostic sensitivity for all reported variants. Results are delivered within 3–4 weeks, accompanied by a telephonic consultation with a DHA‑licensed clinical geneticist.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM–11 PM).
- Clinical Guidance: Post‑test teleconsultation for result interpretation and family risk assessment.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The test uses Next‑Generation Sequencing (NGS) to analyze the full coding region and splice sites of the GJC2 gene. This technology provides comprehensive coverage of all known pathogenic variants, including novel mutations, with a sensitivity exceeding 99.9%. The methodology is superior to single‑gene Sanger sequencing, which is limited to pre‑defined hotspot regions and may miss novel disease‑causing variants.
A detailed clinical history and family pedigree are required before testing. Mandatory pre‑test genetic counselling is arranged to explain the implications of results and to obtain informed consent. No specific dietary or medication restrictions apply.
| Feature | Our GJC2 NGS Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full coding region analysis | Sanger sequencing – targeted to known hotspot regions |
| Detection Rate | >99.9% for all reported pathogenic variants | Limited to pre‑defined mutations; may miss novel variants |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Sample Options | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) | Typically blood only |
Physician Insight & Safety Protocols
“As a DHA‑licensed consultant in medical genetics, I emphasize that genetic testing is a powerful diagnostic tool but must always be correlated with a thorough clinical evaluation and family history. This GJC2 analysis clarifies the diagnosis when clinical signs of hereditary lymphedema are present. However, genetic results should be interpreted within the context of the patient’s full medical picture. Please discuss all findings with your managing physician or a clinical geneticist before making any health decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Pre‑ and Post‑Test Genetic Counselling
All patients are offered pre‑ and post‑test genetic counselling to ensure informed decision‑making and accurate interpretation of results. Counselling addresses inheritance patterns, reproductive risks, and implications for family members. This service is provided at no additional cost.
Exclusion Criteria & Emergency Red Flags
- This test is intended for elective genetic risk assessment and is not suitable for acute diagnostic triage.
- Individuals with active infectious illness should postpone sample collection until fully recovered.
- Seek immediate medical attention if you experience: sudden limb swelling increase, redness, warmth, pain, fever, or difficulty breathing – these may indicate acute cellulitis, deep vein thrombosis, or systemic infection. This test does not address emergent conditions.
Patient FAQ & Clinical Guidance
1. What is the GJC2 gene test?
This test analyzes the GJC2 gene using Next‑Generation Sequencing to diagnose hereditary lymphedema type IC. It identifies disease‑causing mutations that confirm the diagnosis, guide treatment, and assess inheritance risks for family members.
2. How is the sample collected?
A DHA‑licensed phlebotomist collects a peripheral whole blood sample via simple venipuncture, or alternatively an extracted DNA sample or dried blood spot on an FTA card. Our VIP Mobile Phlebotomy service uses ISO‑certified cold‑chain transport to maintain sample integrity. Home collection is available daily from 8 AM to 11 PM.
3. How long do results take and what do they mean?
Results are delivered within 3–4 weeks. A positive result confirms a pathogenic GJC2 mutation and supports a diagnosis of hereditary lymphedema type IC. A negative result suggests that other genetic or non‑genetic causes should be investigated. A post‑test teleconsultation with a clinical geneticist is included to explain the findings and address any questions.
4. Is genetic counselling included?
Yes, pre‑ and post‑test genetic counselling is provided as part of the service. A board‑certified genetic counsellor will help you understand the implications of the test, discuss family planning options, and guide you through the results.
UAE Regulatory & Data Privacy Adherence
Legal & Privacy Compliance
DNA Labs UAE operates under DHA Facility License No. 1143 and adheres to all applicable UAE federal laws, including:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring your medical and genetic data is processed with strict privacy controls.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the secure handling of health information.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – governing clinical testing safety and patient consent.
All genetic data is stored in encrypted servers located within the UAE, accessible only to authorized healthcare professionals. Results are shared only with the patient and their referring physician.
Clinical & Logistical Metadata
| Test Name | GJC2 Gene Hereditary Lymphedema Type IC Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Coding Region & Splice Sites |
| ICD-10-CM Code | Q82.0 (Hereditary lymphedema) |
| LOINC Code | 94801-1 (GJC2 gene sequencing) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians